• Product NameBrimonidine Tartrate
• Brief DescriptionInhibitors
• Purification99.83%
• Biological ActivityBrimonidine Tartrate is a highly selective α-adrenergic receptor agonist with EC50 of 0.45 nM for the α2A adrenoreceptor, and used to treat open-angle glaucoma or ocular hypertension.
• Target NameAdrenergic Receptor agonist
• CAS No. 70359-46-5
• Calculated MW 442.22
• Formulation C15H16BrN5O6
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
  Pathways:GPCR/G Protein
  Receptor:α2A-adrenergic receptor
  Boling pt:
  Melting pt:
  Solubility:Water: 75 mg/mL (169.59 mM); DMSO: 88 mg/mL (198.99 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. WoldeMussie E, et al. Invest Ophthalmol Vis Sci, 2001, 42(12), 2849-2855.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting